{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T04:41:42Z","timestamp":1789015302805,"version":"build-2803163510"},"reference-count":44,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2023,5,30]],"date-time":"2023-05-30T00:00:00Z","timestamp":1685404800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,5,30]],"date-time":"2023-05-30T00:00:00Z","timestamp":1685404800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"Medical Science Research Project of Hebei Province","award":["20210371"],"award-info":[{"award-number":["20210371"]}]},{"DOI":"10.13039\/501100003787","name":"Natural Science Foundation of Hebei Province","doi-asserted-by":"publisher","award":["H2019206196"],"award-info":[{"award-number":["H2019206196"]}],"id":[{"id":"10.13039\/501100003787","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Genes Genom"],"published-print":{"date-parts":[[2023,8]]},"DOI":"10.1007\/s13258-023-01403-8","type":"journal-article","created":{"date-parts":[[2023,5,30]],"date-time":"2023-05-30T16:02:19Z","timestamp":1685462539000},"page":"1003-1011","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Expression profiles and bioinformatic analysis of microRNAs in myocardium of diabetic cardiomyopathy mice"],"prefix":"10.1007","volume":"45","author":[{"given":"Ting","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lingling","family":"Yuan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanxia","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Na","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3356-9175","authenticated-orcid":false,"given":"Hong","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,5,30]]},"reference":[{"key":"1403_CR1","doi-asserted-by":"publisher","first-page":"R762","DOI":"10.1016\/j.cub.2014.06.043","volume":"24","author":"BD Adams","year":"2014","unstructured":"Adams BD, Kasinski AL, Slack FJ (2014) Aberrant regulation and function of microRNAs in cancer. Curr Biol 24:R762\u2013776","journal-title":"Curr Biol"},{"key":"1403_CR2","doi-asserted-by":"publisher","first-page":"609157","DOI":"10.3389\/fphys.2020.609157","volume":"11","author":"J Bai","year":"2020","unstructured":"Bai J, Liu C, Zhu P, Li Y (2020) Novel insights into molecular mechanism of Mitochondria in Diabetic Cardiomyopathy. Front Physiol 11:609157","journal-title":"Front Physiol"},{"key":"1403_CR3","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1016\/S0092-8674(04)00045-5","volume":"116","author":"DP Bartel","year":"2004","unstructured":"Bartel DP (2004) MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 116:281\u2013297","journal-title":"Cell"},{"key":"1403_CR4","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1007\/s11154-010-9131-7","volume":"11","author":"S Boudina","year":"2010","unstructured":"Boudina S, Abel ED (2010) Diabetic cardiomyopathy, causes and effects. Rev Endocr Metab Disord 11:31\u201339","journal-title":"Rev Endocr Metab Disord"},{"key":"1403_CR5","doi-asserted-by":"publisher","first-page":"2924","DOI":"10.2337\/db08-0079","volume":"57","author":"H Bugger","year":"2008","unstructured":"Bugger H, Boudina S, Hu XX, Tuinei J, Zaha VG, Theobald HA, Yun UJ, McQueen AP, Wayment B, Litwin SE et al (2008) Type 1 diabetic akita mouse hearts are insulin sensitive but manifest structurally abnormal mitochondria that remain coupled despite increased uncoupling protein 3. Diabetes 57:2924\u20132932","journal-title":"Diabetes"},{"key":"1403_CR6","doi-asserted-by":"publisher","first-page":"7769","DOI":"10.1002\/jcp.29386","volume":"235","author":"H Che","year":"2020","unstructured":"Che H, Wang Y, Li Y, Lv J, Li H, Liu Y, Dong R, Sun Y, Xu X, Zhao J et al (2020) Inhibition of microRNA-150-5p alleviates cardiac inflammation and fibrosis via targeting Smad7 in high glucose-treated cardiac fibroblasts. J Cell Physiol 235:7769\u20137779","journal-title":"J Cell Physiol"},{"key":"1403_CR7","doi-asserted-by":"crossref","unstructured":"Chen D, Zhang M (2021) GAS5 regulates diabetic cardiomyopathy via miR2213p\/p27 axisassociated autophagy. Mol Med Rep 23","DOI":"10.3892\/mmr.2020.11774"},{"key":"1403_CR8","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1016\/j.ijcard.2017.07.096","volume":"245","author":"DA Chistiakov","year":"2017","unstructured":"Chistiakov DA, Orekhov AN, Bobryshev YV (2017) The impact of FOXO-1 to cardiac pathology in diabetes mellitus and diabetes-related metabolic abnormalities. Int J Cardiol 245:236\u2013244","journal-title":"Int J Cardiol"},{"key":"1403_CR9","doi-asserted-by":"crossref","unstructured":"Colpaert RMW, Calore M (2019) MicroRNAs in Cardiac Diseases. Cells 8","DOI":"10.3390\/cells8070737"},{"key":"1403_CR10","doi-asserted-by":"publisher","first-page":"13514","DOI":"10.1038\/s41598-017-13875-2","volume":"7","author":"CU Copier","year":"2017","unstructured":"Copier CU, Leon L, Fernandez M, Contador D, Calligaris SD (2017) Circulating miR-19b and miR-181b are potential biomarkers for diabetic cardiomyopathy. Sci Rep 7:13514","journal-title":"Sci Rep"},{"key":"1403_CR11","first-page":"633","volume":"4","author":"X Diao","year":"2011","unstructured":"Diao X, Shen E, Wang X, Hu B (2011) Differentially expressed microRNAs and their target genes in the hearts of streptozotocin-induced diabetic mice. Mol Med Rep 4:633\u2013640","journal-title":"Mol Med Rep"},{"key":"1403_CR12","doi-asserted-by":"publisher","first-page":"1160","DOI":"10.1161\/CIRCRESAHA.118.314665","volume":"124","author":"WH Dillmann","year":"2019","unstructured":"Dillmann WH (2019) Diabetic Cardiomyopathy. Circ Res 124:1160\u20131162","journal-title":"Circ Res"},{"key":"1403_CR13","doi-asserted-by":"publisher","first-page":"709123","DOI":"10.3389\/fphys.2021.709123","volume":"12","author":"H Ding","year":"2021","unstructured":"Ding H, Yao J, Xie H, Wang C, Chen J, Wei K, Ji Y, Liu L (2021) MicroRNA-195-5p downregulation inhibits endothelial mesenchymal transition and myocardial fibrosis in Diabetic Cardiomyopathy by Targeting Smad7 and inhibiting transforming growth factor Beta 1-Smads-snail pathway. Front Physiol 12:709123","journal-title":"Front Physiol"},{"key":"1403_CR14","doi-asserted-by":"crossref","unstructured":"Evangelista I, Nuti R, Picchioni T, Dotta F, Palazzuoli A (2019) Molecular dysfunction and phenotypic derangement in Diabetic Cardiomyopathy. Int J Mol Sci 20","DOI":"10.3390\/ijms20133264"},{"key":"1403_CR15","doi-asserted-by":"publisher","first-page":"618","DOI":"10.1089\/ars.2020.8248","volume":"35","author":"F Fu","year":"2021","unstructured":"Fu F, Liu C, Shi R, Li M, Zhang M, Du Y, Wang Q, Li J, Wang G, Pei J et al (2021) Punicalagin protects against Diabetic Cardiomyopathy by promoting Opa1-Mediated mitochondrial Fusion via regulating PTP1B-Stat3 pathway. Antioxid Redox Signal 35:618\u2013641","journal-title":"Antioxid Redox Signal"},{"key":"1403_CR16","doi-asserted-by":"publisher","first-page":"3322","DOI":"10.1016\/j.bbadis.2018.07.019","volume":"1864","author":"L Gao","year":"2018","unstructured":"Gao L, Liu Y, Guo S, Xiao L, Wu L, Wang Z, Liang C, Yao R, Zhang Y (2018) LAZ3 protects cardiac remodeling in diabetic cardiomyopathy via regulating miR-21\/PPARa signaling. Biochim Biophys Acta Mol Basis Dis 1864:3322\u20133338","journal-title":"Biochim Biophys Acta Mol Basis Dis"},{"key":"1403_CR17","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1038\/s41419-017-0093-5","volume":"9","author":"J Gu","year":"2018","unstructured":"Gu J, Wang S, Guo H, Tan Y, Liang Y, Feng A, Liu Q, Damodaran C, Zhang Z, Keller BB et al (2018) Inhibition of p53 prevents diabetic cardiomyopathy by preventing early-stage apoptosis and cell senescence, reduced glycolysis, and impaired angiogenesis. Cell Death Dis 9:82","journal-title":"Cell Death Dis"},{"key":"1403_CR18","doi-asserted-by":"publisher","first-page":"672","DOI":"10.1016\/j.yjmcc.2008.01.012","volume":"44","author":"CS Hong","year":"2008","unstructured":"Hong CS, Kwon SJ, Cho MC, Kwak YG, Ha KC, Hong B, Li H, Chae SW, Chai OH, Song CH et al (2008) Overexpression of junctate induces cardiac hypertrophy and arrhythmia via altered calcium handling. J Mol Cell Cardiol 44:672\u2013682","journal-title":"J Mol Cell Cardiol"},{"key":"1403_CR19","doi-asserted-by":"publisher","first-page":"3687","DOI":"10.7150\/thno.33684","volume":"9","author":"L Hu","year":"2019","unstructured":"Hu L, Ding M, Tang D, Gao E, Li C, Wang K, Qi B, Qiu J, Zhao H, Chang P et al (2019) Targeting mitochondrial dynamics by regulating Mfn2 for therapeutic intervention in diabetic cardiomyopathy. Theranostics 9:3687\u20133706","journal-title":"Theranostics"},{"key":"1403_CR20","doi-asserted-by":"publisher","first-page":"1127","DOI":"10.1126\/science.153.3740.1127","volume":"153","author":"KP Hummel","year":"1966","unstructured":"Hummel KP, Dickie MM, Coleman DL (1966) Diabetes, a new mutation in the mouse. Science 153:1127\u20131128","journal-title":"Science"},{"key":"1403_CR21","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1186\/s12933-021-01245-2","volume":"20","author":"D Jakubik","year":"2021","unstructured":"Jakubik D, Fitas A, Eyileten C, Jarosz-Popek J, Nowak A, Czajka P, Wicik Z, Sourij H, Siller-Matula JM, De Rosa S et al (2021) MicroRNAs and long non-coding RNAs in the pathophysiological processes of diabetic cardiomyopathy: emerging biomarkers and potential therapeutics. Cardiovasc Diabetol 20:55","journal-title":"Cardiovasc Diabetol"},{"key":"1403_CR22","doi-asserted-by":"crossref","unstructured":"Jankauskas SS, Gambardella J, Sardu C, Lombardi A, Santulli G (2021) Functional role of miR-155 in the Pathogenesis of Diabetes Mellitus and its complications. Noncoding RNA 7","DOI":"10.3390\/ncrna7030039"},{"key":"1403_CR23","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1016\/j.bbrc.2016.02.065","volume":"471","author":"P Jeyabal","year":"2016","unstructured":"Jeyabal P, Thandavarayan RA, Joladarashi D, Suresh Babu S, Krishnamurthy S, Bhimaraj A, Youker KA, Kishore R, Krishnamurthy P (2016) MicroRNA-9 inhibits hyperglycemia-induced pyroptosis in human ventricular cardiomyocytes by targeting ELAVL1. Biochem Biophys Res Commun 471:423\u2013429","journal-title":"Biochem Biophys Res Commun"},{"key":"1403_CR24","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1007\/s00125-017-4390-4","volume":"61","author":"G Jia","year":"2018","unstructured":"Jia G, Whaley-Connell A, Sowers JR (2018) Diabetic cardiomyopathy: a hyperglycaemia- and insulin-resistance-induced heart disease. Diabetologia 61:21\u201328","journal-title":"Diabetologia"},{"key":"1403_CR25","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1080\/13813455.2018.1511599","volume":"126","author":"S Khakdan","year":"2020","unstructured":"Khakdan S, Delfan M, Heydarpour Meymeh M, Kazerouni F, Ghaedi H, Shanaki M, Kalaki-Jouybari F, Gorgani-Firuzjaee S, Rahimipour A (2020) High-intensity interval training (HIIT) effectively enhances heart function via miR-195 dependent cardiomyopathy reduction in high-fat high-fructose diet-induced diabetic rats. Arch Physiol Biochem 126:250\u2013257","journal-title":"Arch Physiol Biochem"},{"key":"1403_CR26","doi-asserted-by":"publisher","first-page":"429","DOI":"10.3389\/fphys.2014.00429","volume":"5","author":"Y Lecarpentier","year":"2014","unstructured":"Lecarpentier Y, Claes V, Duthoit G, Hebert JL (2014) Circadian rhythms, Wnt\/beta-catenin pathway and PPAR alpha\/gamma profiles in diseases with primary or secondary cardiac dysfunction. Front Physiol 5:429","journal-title":"Front Physiol"},{"key":"1403_CR27","doi-asserted-by":"publisher","first-page":"4243","DOI":"10.1093\/eurheartj\/ehy596","volume":"39","author":"C Maack","year":"2018","unstructured":"Maack C, Lehrke M, Backs J, Heinzel FR, Hulot JS, Marx N, Paulus WJ, Rossignol P, Taegtmeyer H, Bauersachs J et al (2018) Heart failure and diabetes: metabolic alterations and therapeutic interventions: a state-of-the-art review from the Translational Research Committee of the heart failure Association-European Society of Cardiology. Eur Heart J 39:4243\u20134254","journal-title":"Eur Heart J"},{"key":"1403_CR28","doi-asserted-by":"publisher","first-page":"313","DOI":"10.2174\/1566523221666210311111619","volume":"21","author":"P Mathur","year":"2021","unstructured":"Mathur P, Rani V (2021) MicroRNAs: a critical Regulator and a Promising Therapeutic and Diagnostic Molecule for Diabetic Cardiomyopathy. Curr Gene Ther 21:313\u2013326","journal-title":"Curr Gene Ther"},{"key":"1403_CR29","doi-asserted-by":"publisher","first-page":"725532","DOI":"10.3389\/fcvm.2021.725532","volume":"8","author":"A Mittal","year":"2021","unstructured":"Mittal A, Garg R, Bahl A, Khullar M (2021) Molecular Mechanisms and Epigenetic Regulation in Diabetic Cardiomyopathy. Front Cardiovasc Med 8:725532","journal-title":"Front Cardiovasc Med"},{"key":"1403_CR30","doi-asserted-by":"publisher","first-page":"554","DOI":"10.1161\/CIRCULATIONAHA.113.008476","volume":"130","author":"D Montaigne","year":"2014","unstructured":"Montaigne D, Marechal X, Coisne A, Debry N, Modine T, Fayad G, Potelle C, El Arid JM, Mouton S, Sebti Y et al (2014) Myocardial contractile dysfunction is associated with impaired mitochondrial function and dynamics in type 2 diabetic but not in obese patients. Circulation 130:554\u2013564","journal-title":"Circulation"},{"key":"1403_CR31","doi-asserted-by":"publisher","first-page":"1375","DOI":"10.2337\/dc13-1847","volume":"37","author":"FJ Ortega","year":"2014","unstructured":"Ortega FJ, Mercader JM, Moreno-Navarrete JM, Rovira O, Guerra E, Esteve E, Xifra G, Martinez C, Ricart W, Rieusset J et al (2014) Profiling of circulating microRNAs reveals common microRNAs linked to type 2 diabetes that change with insulin sensitization. Diabetes Care 37:1375\u20131383","journal-title":"Diabetes Care"},{"key":"1403_CR32","doi-asserted-by":"publisher","first-page":"855","DOI":"10.1111\/dom.12688","volume":"18","author":"F Prattichizzo","year":"2016","unstructured":"Prattichizzo F, Giuliani A, De Nigris V, Pujadas G, Ceka A, La Sala L, Genovese S, Testa R, Procopio AD, Olivieri F et al (2016) Extracellular microRNAs and endothelial hyperglycaemic memory: a therapeutic opportunity? Diabetes Obes Metab 18:855\u2013867","journal-title":"Diabetes Obes Metab"},{"key":"1403_CR33","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1007\/s11010-016-2729-7","volume":"417","author":"SK Raut","year":"2016","unstructured":"Raut SK, Singh GB, Rastogi B, Saikia UN, Mittal A, Dogra N, Singh S, Prasad R, Khullar M (2016) miR-30c and miR-181a synergistically modulate p53-p21 pathway in diabetes induced cardiac hypertrophy. Mol Cell Biochem 417:191\u2013203","journal-title":"Mol Cell Biochem"},{"key":"1403_CR34","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1038\/s41581-019-0248-y","volume":"16","author":"M Ruiz-Ortega","year":"2020","unstructured":"Ruiz-Ortega M, Rayego-Mateos S, Lamas S, Ortiz A, Rodrigues-Diez RR (2020) Targeting the progression of chronic kidney disease. Nat Rev Nephrol 16:269\u2013288","journal-title":"Nat Rev Nephrol"},{"key":"1403_CR35","doi-asserted-by":"publisher","first-page":"2173","DOI":"10.1096\/fj.201901838R","volume":"34","author":"L Tao","year":"2020","unstructured":"Tao L, Huang X, Xu M, Yang L, Hua F (2020) MiR-144 protects the heart from hyperglycemia-induced injury by regulating mitochondrial biogenesis and cardiomyocyte apoptosis. FASEB J 34:2173\u20132197","journal-title":"FASEB J"},{"key":"1403_CR36","doi-asserted-by":"publisher","first-page":"143995","DOI":"10.1016\/j.gene.2019.143995","volume":"715","author":"X Yang","year":"2019","unstructured":"Yang X, Li X, Lin Q, Xu Q (2019) Up-regulation of microRNA-203 inhibits myocardial fibrosis and oxidative stress in mice with diabetic cardiomyopathy through the inhibition of PI3K\/Akt signaling pathway via PIK3CA. Gene 715:143995","journal-title":"Gene"},{"key":"1403_CR37","doi-asserted-by":"publisher","first-page":"1397","DOI":"10.1007\/s12013-013-9672-y","volume":"67","author":"SS Yildirim","year":"2013","unstructured":"Yildirim SS, Akman D, Catalucci D, Turan B (2013) Relationship between downregulation of miRNAs and increase of oxidative stress in the development of diabetic cardiac dysfunction: junctin as a target protein of miR-1. Cell Biochem Biophys 67:1397\u20131408","journal-title":"Cell Biochem Biophys"},{"key":"1403_CR38","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1186\/s12933-019-0811-7","volume":"18","author":"Z Yin","year":"2019","unstructured":"Yin Z, Zhao Y, He M, Li H, Fan J, Nie X, Yan M, Chen C, Wang DW (2019) MiR-30c\/PGC-1beta protects against diabetic cardiomyopathy via PPARalpha. Cardiovasc Diabetol 18:7","journal-title":"Cardiovasc Diabetol"},{"key":"1403_CR39","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1016\/j.carpath.2015.06.003","volume":"24","author":"M Yu","year":"2015","unstructured":"Yu M, Liu Y, Zhang B, Shi Y, Cui L, Zhao X (2015) Inhibiting microRNA-144 abates oxidative stress and reduces apoptosis in hearts of streptozotocin-induced diabetic mice. Cardiovasc Pathol 24:375\u2013381","journal-title":"Cardiovasc Pathol"},{"key":"1403_CR41","first-page":"6346","volume":"24","author":"WY Zhang","year":"2020","unstructured":"Zhang WY, Wang J, Li AZ (2020) A study of the effects of SGLT-2 inhibitors on diabetic cardiomyopathy through miR-30d\/KLF9\/VEGFA pathway. Eur Rev Med Pharmacol Sci 24:6346\u20136359","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"1403_CR40","doi-asserted-by":"publisher","first-page":"8624","DOI":"10.7150\/thno.48561","volume":"11","author":"M Zhang","year":"2021","unstructured":"Zhang M, Sui W, Xing Y, Cheng J, Cheng C, Xue F, Zhang J, Wang X, Zhang C, Hao P et al (2021) Angiotensin IV attenuates diabetic cardiomyopathy via suppressing FoxO1-induced excessive autophagy, apoptosis and fibrosis. Theranostics 11:8624\u20138639","journal-title":"Theranostics"},{"key":"1403_CR42","first-page":"718","volume":"12","author":"L Zhao","year":"2020","unstructured":"Zhao L, Li W, Zhao H (2020) Inhibition of long non-coding RNA TUG1 protects against diabetic cardiomyopathy induced diastolic dysfunction by regulating miR-499-5p. Am J Transl Res 12:718\u2013730","journal-title":"Am J Transl Res"},{"key":"1403_CR43","doi-asserted-by":"publisher","first-page":"999","DOI":"10.1038\/aps.2011.54","volume":"32","author":"H Zhou","year":"2011","unstructured":"Zhou H, Li YJ, Wang M, Zhang LH, Guo BY, Zhao ZS, Meng FL, Deng YG, Wang RY (2011) Involvement of RhoA\/ROCK in myocardial fibrosis in a rat model of type 2 diabetes. Acta Pharmacol Sin 32:999\u20131008","journal-title":"Acta Pharmacol Sin"},{"key":"1403_CR44","doi-asserted-by":"publisher","first-page":"e3022","DOI":"10.1002\/dmrr.3022","volume":"34","author":"H Zhou","year":"2018","unstructured":"Zhou H, Sun Y, Zhang L, Kang W, Li N, Li Y (2018) The RhoA\/ROCK pathway mediates high glucose-induced cardiomyocyte apoptosis via oxidative stress, JNK, and p38MAPK pathways. Diabetes Metab Res Rev 34:e3022","journal-title":"Diabetes Metab Res Rev"}],"container-title":["Genes & Genomics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13258-023-01403-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s13258-023-01403-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13258-023-01403-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,7,15]],"date-time":"2023-07-15T15:06:20Z","timestamp":1689433580000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s13258-023-01403-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,5,30]]},"references-count":44,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2023,8]]}},"alternative-id":["1403"],"URL":"https:\/\/doi.org\/10.1007\/s13258-023-01403-8","relation":{},"ISSN":["1976-9571","2092-9293"],"issn-type":[{"value":"1976-9571","type":"print"},{"value":"2092-9293","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,5,30]]},"assertion":[{"value":"20 September 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 May 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 May 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"None of the authors have any potential conflicts of interest associated with this research.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of interest"}}]}}